期刊
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
卷 43, 期 3, 页码 324-327出版社
OXFORD UNIV PRESS
DOI: 10.1093/jjco/hys220
关键词
gastric cancer; laparoscopic surgery; gastrectomy; clinical trial; Phase III
类别
资金
- Health and Labour Sciences Research Grant for Clinical Cancer Research from the Ministry of Health, Labour and Welfare of Japan [H21-019, H24-009]
- National Cancer Center Research and Development Fund [23-A-16, 23-A-19]
- Grants-in-Aid for Scientific Research [25460896] Funding Source: KAKEN
A Phase III study was started in Japan to evaluate the non-inferiority of overall survival of laparoscopy-assisted distal gastrectomy with open distal gastrectomy in patients with clinical IA (T1N0) or IB [T1N1 or T2(MP)N0] gastric cancer. This study followed the previous Phase II study to confirm the safety of laparoscopy-assisted distal gastrectomy (JCOG0703) and began in March 2010. A total of 920 patients will be accrued from 33 institutions within 5 years. The primary endpoint is overall survival. The secondary endpoints are relapse-free survival, proportion of laparoscopy-assisted distal gastrectomy completion, proportion of conversion to open surgery, adverse events, short-term clinical outcomes, postoperative quality of life. Only a credentialed surgeon can be responsible for both open distal gastrectomy and laparoscopy-assisted distal gastrectomy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据